Use of Intravenous Amiodarone in the Treatment of Nifekalant-Resistant Arrhythmia: A Review of 11 Consecutive Cases with Severe Heart Failure

Use of Intravenous Amiodarone in the Treatment of Nifekalant-Resistant Arrhythmia: A Review of 11 Consecutive Cases with Severe Heart Failure

Background: Both nifekalant hydrochloride (NIF), a selective IKr blocker, and intravenous amiodarone (AMD), a multi-channel (including IKr blocking) blocker, have been reported to be efficacious for refractory arrhythmias. However, the optimal use of those antiarrhythmic drugs for refractory arrhyth...

Full description

Bibliographic Details
Main Authors: Tohru Ujihira, Hiroshi Ito, Hiroshi Morita, Takeshi Tada, Kunihisa Kohno, Yoshiki Hata, Kengo Fukushima Kusano, Koji Nakagawa, Kazufumi Nakamura, Satoshi Nagase, Tohru Ohe, Masato Murakami, Kazumasa Hina
Format: Article
Language:English
Published: MDPI AG 2011-05-01
Series:Pharmaceuticals
Subjects:
arrhythmias
heart failure
ventricular arrhythmia
atrial fibrillation
Online Access:http://www.mdpi.com/1424-8247/4/6/794/

Similar Items

Similar Items